Miura, Shin-ichiro
Saku, Keijiro
Article History
First Online: 10 July 2014
Competing interests
: KS and SM have received grants and lecture honoraria from Daiichi-Sankyo Co. Ltd., MSD, Dainippon Sumitomo Pharma Co. Ltd., Takeda Pharma Co. Ltd., Novartis Pharma, Boehringer Ingelheim and Astellas Pharma Inc. KS is a Chief Director, and SM is a Director of NPO Clinical and Applied Science, Fukuoka, Japan. KS has an Endowed Department of ‘Department of Molecular Cardiovascular Therapeutics’ supported by MSD, Co. LTD. SM belongs to the Department of Molecular Cardiovascular Therapeutics supported by MSD, Co. LTD.